![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Scuffham P.A. Chaplin S.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.22, Iss.8, 2004-01, pp. : 525-535
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Dorsch MF Blackman DJ Greenwood JP Blaxill JM Priestley C Hunter S Jani M McLenachan JM
Clinical Medicine, Vol. 8, Iss. 3, 2008-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin: efficacy and safety in reducing cardiac events
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluvastatin viable option for preventing cardiac events
Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. :